Clinical trial
Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients
NCT00493896 · Eastern Virginia Medical School, Other · Terminated
Key facts
| NCT number | NCT00493896 |
|---|---|
| Title | Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients |
| Official title | Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients: An Investigator Initiated Protocol |
| Lead sponsor | Eastern Virginia Medical School, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | Fondaparinux, Enoxaparin |
| Enrollment | 27 |
| Start date | Jul 1, 2007 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Jun 28, 2007 |
| Last update posted | Apr 11, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: